ABCL - Abcellera Biologics Inc.

Over the past 90 days, insiders at Abcellera Biologics Inc. (ABCL) have been net buyers, picking up 147,200 shares worth roughly $1.5M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Thermopylae Holdings Ltd.	56.13M	$683.71M	-
Dir	Michael R Hayden	1.37M	$16.73M	-
CFO	Andrew Booth	482.8K	$5.88M	-
Dir	John S. Montalbano	251.0K	$3.06M	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2025	John S. Montalbano55	Director	Buy	25,000	$2.30	$57,500.00	+17.1%	+14.1%	+62.7%
Mar 6, 2025	John S. Montalbano55	Director	Buy	60,000	$2.34	$140,568.00	+69.8%	+1.7%	+45.4%
Aug 29, 2024	Thermopylae Holdings Ltd.64	10% Owner	Buy	283,516	$2.61	$739,976.76	+0.5%	+18.6%	+65.2%
Nov 8, 2023	John S. Montalbano55	Director	Buy	30,000	$4.58	$137,400.00	+53.6%	+23.9%	-34.9%
Sep 22, 2023	Michael R Hayden59	Director	Buy	20,000	$4.91	$98,200.00	+1.5%	+13.8%	-48.2%
Sep 12, 2023	Veronique Lecault48	Chief Operating Officer	Buy	20,000	$5.19	$103,800.00	+1.0%	-6.8%	-47.7%
Aug 8, 2023	Michael R Hayden59	Director	Buy	30,000	$5.90	$177,000.00	+2.4%	-24.0%	-55.3%
May 26, 2023	Andrew Booth47	Chief Financial Officer	Buy	14,500	$6.85	$99,325.00	+10.5%	-19.1%	-43.4%
May 26, 2023	Thermopylae Holdings Ltd.64	10% Owner	Buy	153,000	$6.52	$997,728.30	+0.3%	-19.1%	-43.4%
Dec 16, 2022	Thermopylae Holdings Ltd.64	10% Owner	Buy	85,102	$10.10	$859,249.36	+0.2%	-26.7%	-46.8%